SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $12,823 | +47.5% | 116 | 0.0% | 0.00% | – |
Q2 2022 | $8,695 | -4.0% | 116 | 0.0% | 0.00% | – |
Q1 2022 | $9,062 | -13.2% | 116 | 0.0% | 0.00% | – |
Q4 2021 | $10,446 | -2.6% | 116 | 0.0% | 0.00% | – |
Q3 2021 | $10,728 | -51.7% | 116 | -59.4% | 0.00% | -100.0% |
Q2 2021 | $22,234 | -19.2% | 286 | -22.5% | 0.00% | 0.0% |
Q1 2021 | $27,502 | -55.2% | 369 | +2.5% | 0.00% | -66.7% |
Q4 2020 | $61,376 | +22.1% | 360 | +0.6% | 0.00% | 0.0% |
Q3 2020 | $50,274 | +60.0% | 358 | +82.7% | 0.00% | +50.0% |
Q2 2020 | $31,427 | +63.9% | 196 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $19,173 | -27.9% | 196 | -4.9% | 0.00% | 0.0% |
Q4 2019 | $26,582 | +2.5% | 206 | -41.1% | 0.00% | -50.0% |
Q1 2018 | $25,932 | +55.4% | 350 | +16.7% | 0.00% | +33.3% |
Q4 2017 | $16,692 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |